Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/16/15 → 10/16/18 |
Funding
- CTI Clinical Trial and Consulting Services (Prot # SGTP-002 // Prot # SGTP-002)
- Prolong Pharmaceuticals, LLC (Prot # SGTP-002 // Prot # SGTP-002)
Prot # SGTP-002:A Randomized, Placebo-controlled, Prospective, Double-blind, Multicenter Phase 2/3 Study of the Efficacy and Safety of SANGUINATE for Reduction of Delayed Graft Function in Recipients of a Donation after Brain Death Kidney Transplant
- Gallon, Lorenzo (PD/PI)
Project: Research project